Giorgio V - Search Results

1

Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease.

Miele L, Giorgio V, Liguori A, Petta S, Pastorino R, Arzani D, Alberelli MA, Cefalo C, Marrone G, Biolato M, Rapaccini G, Boccia S, Gasbarrini A, Craxì A, Grieco A. Miele L, et al. Among authors: giorgio v. Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):2103-2110. doi: 10.1016/j.numecd.2020.06.013. Epub 2020 Jun 27. Nutr Metab Cardiovasc Dis. 2020. PMID: 32807638

2

Celiac disease: what's new about it?

Gasbarrini G, Malandrino N, Giorgio V, Fundarò C, Cammarota G, Merra G, Roccarina D, Gasbarrini A, Capristo E. Gasbarrini G, et al. Among authors: giorgio v. Dig Dis. 2008;26(2):121-7. doi: 10.1159/000116769. Epub 2008 Apr 21. Dig Dis. 2008. PMID: 18431061 Review.

3

Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.

Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C, Gasbarrini A. Scarpellini E, et al. Among authors: giorgio v. J Pediatr. 2009 Sep;155(3):416-20. doi: 10.1016/j.jpeds.2009.03.033. Epub 2009 Jun 16. J Pediatr. 2009. PMID: 19535093

4

Fecal calprotectin concentration in children affected by SIBO.

Fundarò C, Fantacci C, Ansuini V, Giorgio V, Filoni S, Barbaro F, Gasbarrini A, Rossi C. Fundarò C, et al. Among authors: giorgio v. Eur Rev Med Pharmacol Sci. 2011 Nov;15(11):1328-35. Eur Rev Med Pharmacol Sci. 2011. PMID: 22195368

5

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.

Giorgio V, Prono F, Graziano F, Nobili V. Giorgio V, et al. BMC Pediatr. 2013 Mar 25;13:40. doi: 10.1186/1471-2431-13-40. BMC Pediatr. 2013. PMID: 23530957 Free PMC article. Review.

6

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A. Scarpellini E, et al. Among authors: giorgio v. Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20. Eur Rev Med Pharmacol Sci. 2013. PMID: 23740443 Free article. Clinical Trial.

7

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.

Giorgio V, Miele L, Principessa L, Ferretti F, Villa MP, Negro V, Grieco A, Alisi A, Nobili V. Giorgio V, et al. Dig Liver Dis. 2014 Jun;46(6):556-60. doi: 10.1016/j.dld.2014.02.010. Epub 2014 Mar 12. Dig Liver Dis. 2014. PMID: 24631029

8

Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A. Miele L, et al. Among authors: giorgio v. Curr Cardiol Rep. 2015 Dec;17(12):120. doi: 10.1007/s11886-015-0671-z. Curr Cardiol Rep. 2015. PMID: 26497040 Review.

9

Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome.

Miele L, Gasbarrini G, Giorgio V, Gasbarrini A, Grieco A. Miele L, et al. Among authors: giorgio v. Intern Emerg Med. 2016 Feb;11(1):3-10. doi: 10.1007/s11739-015-1346-x. Epub 2015 Nov 24. Intern Emerg Med. 2016. PMID: 26602387 No abstract available.

10

Digestive Enzyme Supplementation in Gastrointestinal Diseases.

Ianiro G, Pecere S, Giorgio V, Gasbarrini A, Cammarota G. Ianiro G, et al. Among authors: giorgio v. Curr Drug Metab. 2016;17(2):187-93. doi: 10.2174/138920021702160114150137. Curr Drug Metab. 2016. PMID: 26806042 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters